LUYUAN GP HLDG (02451) · Company profile · Eqvero

LUYUAN GP HLDG

02451HKEX

Unit: CNY	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	5.91 bn CNY	5.07 bn CNY	5.08 bn CNY	4.78 bn CNY	3.42 bn CNY
Cost of revenue	4.97 bn CNY	4.3 bn CNY	4.31 bn CNY	4.15 bn CNY	2.97 bn CNY
Research and development expense	240.22 m CNY	231.17 m CNY	189.4 m CNY	150.5 m CNY	95.83 m CNY
Selling, general and administrative expense	472.86 m CNY	415.46 m CNY	415.47 m CNY	348.63 m CNY	256.83 m CNY
Operating profit after depreciation	155.9 m CNY	83.35 m CNY	61.48 m CNY	93.34 m CNY	50.07 m CNY
Operating profit before depreciation	283.26 m CNY	192.17 m CNY	153.21 m CNY	168.75 m CNY	113.48 m CNY
EBIT	155.9 m CNY	83.35 m CNY	61.48 m CNY	93.34 m CNY	50.07 m CNY
EBITDA	283.26 m CNY	192.17 m CNY	153.21 m CNY	168.75 m CNY	113.48 m CNY
Interest expense	20.56 m CNY	21.98 m CNY	21.98 m CNY	24.77 m CNY	15.38 m CNY
Profit before tax	186.9 m CNY	125.43 m CNY	151.14 m CNY	122.25 m CNY	61.59 m CNY
Income tax expense	11.8 m CNY	9.36 m CNY	5.53 m CNY	4.22 m CNY	2.33 m CNY
Income before extraordinary items	175.1 m CNY	116.76 m CNY	145.61 m CNY	118.03 m CNY	59.26 m CNY
Common dividends	—	57.79 m CNY	—	—	—
Total dividends	—	57.79 m CNY	—	—	—

Quotes are end-of-day data. Content is for research purposes and is not investment advice.